Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitors.
J Med Chem
; 58(4): 1929-39, 2015 Feb 26.
Article
in En
| MEDLINE
| ID: mdl-25625541
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Spleen
/
Protein-Tyrosine Kinases
/
Protein Kinase Inhibitors
/
Ether-A-Go-Go Potassium Channels
/
Amides
Type of study:
Qualitative_research
Limits:
Humans
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2015
Document type:
Article
Affiliation country:
United States
Country of publication:
United States